{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:07:05Z","timestamp":1790287625576,"version":"4.1.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.transproceed.2022.04.015","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T23:16:00Z","timestamp":1653002160000},"page":"1557-1560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Paxlovid (Nirmatelvir\/Ritonavir) and Tacrolimus Drug-Drug Interaction in a Kidney Transplant Patient with SARS-2-CoV infection: A Case Report"],"prefix":"10.1016","volume":"54","author":[{"given":"Marios","family":"Prikis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2022.04.015_bib0001","unstructured":"ClinicalTrials.gov. EPIC-HR: Study of Oral PF-07321332\/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19. ClinicalTrials.gov Identifier: NCT04960202, https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04960202; 2021 [accessed 12.27.21]."},{"key":"10.1016\/j.transproceed.2022.04.015_bib0002","unstructured":"US Food and Drug Administration (FDA). Fact sheet for healthcare providers: emergency use authorization for Paxlovid (nirmatrelvir and ritonavir), https:\/\/www.fda.gov\/media\/155050\/download; 2021 [accessed 12.22.21]."},{"key":"10.1016\/j.transproceed.2022.04.015_bib0003","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/aor.13551","article-title":"Tacrolimus: 20 years of use in adult kidney transplantation. What we should know about its nephrotoxicity","volume":"44","author":"Bentata","year":"2020","journal-title":"Artif Organs"},{"key":"10.1016\/j.transproceed.2022.04.015_bib0004","first-page":"104","article-title":"Morphologic diagnosis of cyclosporine nephrotoxicity","volume":"5","author":"Mihatsch","year":"1988","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.transproceed.2022.04.015_bib0005","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0009-9120(00)00163-6","article-title":"Evaluation of microparticle enzyme immunoassay against HPLC-mass spectrometry for the determination of whole-blood tacrolimus in heart- and lung-transplant recipients","volume":"33","author":"Salm","year":"2000","journal-title":"Clin Biochem"},{"key":"10.1016\/j.transproceed.2022.04.015_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2008.06.007","article-title":"Comparison of the CEDIA and MEIA assays for measurement of tacrolimus in organ transplant recipients","volume":"396","author":"Liang","year":"2008","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.transproceed.2022.04.015_bib0007","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1309\/AJCPB6EUC5QHLGNV","article-title":"Comparison of CEDIA FK506 assay with HPLC\/MS\/MS in a large cohort of pediatric patients","volume":"139","author":"Lower","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.transproceed.2022.04.015_bib0008","first-page":"302","article-title":"Isolation and mass spectrometric identification of five metabolites of FK-506, a novel macrolide immunosuppressive agent, from human plasma","volume":"66","author":"Lho\u00ebst","year":"1991","journal-title":"Pharm Acta Helv"},{"key":"10.1016\/j.transproceed.2022.04.015_bib0009","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0090-9556(25)08219-4","article-title":"Isolation, identification, and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone","volume":"21","author":"Iwasaki","year":"1993","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.transproceed.2022.04.015_bib0010","doi-asserted-by":"crossref","first-page":"n2713","DOI":"10.1136\/bmj.n2713","article-title":"Covid-19: Pfizer's Paxlovid is 89% effective in patients at risk of serious illness, company reports","volume":"375","author":"Mahase","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.transproceed.2022.04.015_bib0011","unstructured":"LiverTox: Clinical and research information on drug-induced liver injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases. Paxlovid. 2022. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK577815\/; [accessed 01.31.22]."}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113452200286X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113452200286X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:40:40Z","timestamp":1758577240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004113452200286X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S004113452200286X"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2022.04.015","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paxlovid (Nirmatelvir\/Ritonavir) and Tacrolimus Drug-Drug Interaction in a Kidney Transplant Patient with SARS-2-CoV infection: A Case Report","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2022.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}